Lonza Group Ltd (LZAGY)
58.09
+0.17
(+0.29%)
USD |
OTCM |
May 17, 16:00
Lonza Group Revenue (TTM): 7.531B for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.531B |
| June 30, 2023 | 6.793B |
| December 31, 2022 | 6.458B |
| June 30, 2022 | 6.200B |
| December 31, 2021 | 5.901B |
| June 30, 2021 | 5.297B |
| December 31, 2020 | 4.833B |
| June 30, 2020 | 3.571B |
| December 31, 2019 | 4.211B |
| June 30, 2019 | 5.725B |
| December 31, 2018 | 5.596B |
| June 30, 2018 | 5.105B |
| December 31, 2017 | 4.611B |
| June 30, 2017 | 4.456B |
| December 31, 2016 | 4.191B |
| June 30, 2016 | 3.995B |
| Date | Value |
|---|---|
| December 31, 2015 | 3.936B |
| June 30, 2015 | 3.928B |
| December 31, 2014 | 3.932B |
| June 30, 2014 | 4.062B |
| December 31, 2013 | 3.887B |
| June 30, 2013 | 3.956B |
| December 31, 2012 | 4.204B |
| June 30, 2012 | 3.741B |
| December 31, 2011 | 3.015B |
| June 30, 2011 | 2.788B |
| December 31, 2010 | 2.590B |
| June 30, 2010 | 2.507B |
| December 31, 2009 | 2.529B |
| June 30, 2009 | 2.472B |
| December 31, 2008 | 2.694B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
3.571B
Minimum
Jun 2020
7.531B
Maximum
Dec 2023
5.652B
Average
5.813B
Median
Revenue (TTM) Benchmarks
| Roche Holding AG | 67.72B |
| AC Immune SA | -- |
| CRISPR Therapeutics AG | -- |
| Addex Therapeutics Ltd | 1.787M |
| NLS Pharmaceutics Ltd | -- |